Clinical trial

A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension

NCT07116863

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-06-21

PhasePHASE3

Study timeline

Study start (actual)2022-06-21Date precision: day

Registry last updated2025-08-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential Hypertensionunresolved

Interventions

KDF1901-R0DRUG

KDF1901-LDRUG

KDF1901DRUG

KDF1901-R1DRUG

Sponsors & collaborators

Kyungdong Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

SeoulSouth Korea2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07116863 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.